Q Line Biotech Ltd vs Tusaldah Limited Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Q-Line Biotech Ltd is ₹ 529.55 as of 23 Oct 15:30 . The P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Tusaldah Limited changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 years The Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Tusaldah Limited changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 years The Revenue of Q-Line Biotech Ltd is ₹ 90.03 crore as of Dec '25 .The Revenue of Tusaldah Limited is ₹ 0 crore as of Dec '25 . The EBITDA of Q-Line Biotech Ltd is ₹ 30.54 crore as of Dec '25 .The EBITDA of Tusaldah Limited is ₹ 0 crore as of Dec '25 . The Net Profit of Q-Line Biotech Ltd is ₹ 17.38 crore as of Dec '25 .The Net Profit of Tusaldah Limited is ₹ 0 crore as of Dec '25 . The Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Tusaldah Limited changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

About Tusaldah Limited

Tusaldah Limited was initially established as High Street Filatex Limited in 1994 and the name of the Company was changed to Tusaldah Limited in August 2025.
It is engaged in Trading of Knitted Socks, head band and wrist band and trading in yarn and commodities. The Company harbors extensive expansion plans and is geared of install 100 more machines in a short while, for which the constructions of new factory is going in full swing.
It has most strategically located plant and has adopted advanced production techniques.
It is capable of making socks of different designs/patterns.

FAQs for the comparison of Q-Line Biotech Ltd and Tusaldah Limited

Which company has a larger market capitalization, Q-Line Biotech Ltd or Tusaldah Limited?

Market cap of Q-Line Biotech Ltd is 1,235 Cr while Market cap of Tusaldah Limited is 27 Cr

What are the key factors driving the stock performance of Q-Line Biotech Ltd and Tusaldah Limited?

The stock performance of Q-Line Biotech Ltd and Tusaldah Limited is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Q-Line Biotech Ltd and Tusaldah Limited?

As of October 25, 2026, the Q-Line Biotech Ltd stock price is INR ₹529.55. On the other hand, Tusaldah Limited stock price is INR ₹118.95.

How do dividend payouts of Q-Line Biotech Ltd and Tusaldah Limited compare?

To compare the dividend payouts of Q-Line Biotech Ltd and Tusaldah Limited, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.